- Home
- WSBF vs JSPR Comparison
WSBF vs JSPR Comparison
Compare WSBF & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSBF
- JSPR
- Stock Information
- Founded
- WSBF 1921
- JSPR 2018
- Country
- WSBF United States
- JSPR United States
- Employees
- WSBF N/A
- JSPR N/A
- Industry
- WSBF Savings Institutions
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WSBF Finance
- JSPR Health Care
- Exchange
- WSBF Nasdaq
- JSPR Nasdaq
- Market Cap
- WSBF 296.4M
- JSPR 325.7M
- IPO Year
- WSBF N/A
- JSPR N/A
- Fundamental
- Price
- WSBF $13.67
- JSPR $22.50
- Analyst Decision
- WSBF
- JSPR Strong Buy
- Analyst Count
- WSBF 0
- JSPR 11
- Target Price
- WSBF N/A
- JSPR $73.38
- AVG Volume (30 Days)
- WSBF 41.6K
- JSPR 176.2K
- Earning Date
- WSBF 01-28-2025
- JSPR 11-07-2024
- Dividend Yield
- WSBF 4.42%
- JSPR N/A
- EPS Growth
- WSBF 40.34
- JSPR N/A
- EPS
- WSBF 0.71
- JSPR N/A
- Revenue
- WSBF $133,232,000.00
- JSPR N/A
- Revenue This Year
- WSBF N/A
- JSPR N/A
- Revenue Next Year
- WSBF N/A
- JSPR N/A
- P/E Ratio
- WSBF $19.10
- JSPR N/A
- Revenue Growth
- WSBF N/A
- JSPR N/A
- 52 Week Low
- WSBF $10.60
- JSPR $6.20
- 52 Week High
- WSBF $16.86
- JSPR $31.01
- Technical
- Relative Strength Index (RSI)
- WSBF 30.92
- JSPR 53.62
- Support Level
- WSBF $13.30
- JSPR $20.77
- Resistance Level
- WSBF $14.97
- JSPR $23.11
- Average True Range (ATR)
- WSBF 0.38
- JSPR 1.59
- MACD
- WSBF -0.14
- JSPR -0.01
- Stochastic Oscillator
- WSBF 19.37
- JSPR 68.97
About WSBF Waterstone Financial Inc. (MD)
Waterstone Financial Inc is a holding company. Through its subsidiaries, It operates in two segments: Community Banking and Mortgage Banking. The community banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the community banking segment.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.